InVision AG
XETRA:IVX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
InVision AG
XETRA:IVX
|
DE |
|
P
|
Power REIT
AMEX:PW
|
US |
|
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
KR |
|
C
|
Colonial Coal International Corp
XTSX:CAD
|
CA |
|
Power REIT
F:P8P
|
US |
|
Carisma Therapeutics Inc
NASDAQ:CARM
|
US |
|
L
|
Lithium Australia NL
ASX:LITCF
|
AU |
|
Lawson Inc
TSE:2651
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IVX's stock price target?
Not Available
IVX doesn't have any price targets made by Wall Street professionals.
What is InVision AG's Revenue forecast?
Projected CAGR
35%
For the last 8 years the
compound annual growth rate for
InVision AG's revenue is
1%.
The projected
CAGR
for the next 1 year is
35%.